// App-Quantinova.ai

: MiR-1-5p targets TGF-ßR1 and is suppressed in the hypertrophying hearts of rats with pulmonary arterial hypertension

Researchers

Presenter

  • Martin Connolly

Principal Investigators

  • Stephen Wort

  • Benjamin Garfield

  • Alexi Crosby

  • Nick Morrell

  • Paul Kemp

Medical Centers

  • Imperial College, London, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • University of Cambridge, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

  • Hypertrophic cardiomyopathy

  • Hypertension

Biomarkers

  • Transforming growth factor beta

  • Transforming Growth Factor Beta Receptor 1

Drug/Treatment

  • Monocrotaline

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A